Picture of Cullinan Therapeutics logo

CGEM — Cullinan Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Brief: Cullinan Therapeutics Q1 Operating Expenses USD 53.697 Million

May 07 (Reuters) - Cullinan Therapeutics Q1 net income USD -49.661 million.

Q1 operating income USD -53.697 million vs. IBES estimate USD -56.6 million

Q1 cash & investments USD 393.3 million

Recent news on Cullinan Therapeutics

See all news